Menu Search
Equities

Jeena Sikho Lifecare Ltd

JSLL:NSI

Jeena Sikho Lifecare Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,388.70
  • Today's Change-30.15 / -2.12%
  • Shares traded17.10k
  • 1 Year change+138.06%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 10:58 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year Jeena Sikho Lifecare Ltd grew revenues 43.84% from 944.17m to 1.36bn while net income improved 77.37% from 57.26m to 101.56m.
Gross margin--
Net profit margin--
Operating margin--
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in INRView more

In 2021, Jeena Sikho Lifecare Ltd increased its cash reserves by 523.90%, or 75.26m. The company earned 175.28m from its operations for a Cash Flow Margin of 12.91%. In addition the company used 84.69m on investing activities and also paid 15.32m in financing cash flows.
Cash flow per share--
Price/Cash flow per share--
Book value per share12.72
Tangible book value per share12.64
More ▼

Balance sheet in INRView more

Jeena Sikho Lifecare Ltd has a Debt to Total Capital ratio of 26.81%.
Current ratio1.11
Quick ratio0.8228
Total debt/total equity0.3663
Total debt/total capital0.2681
More ▼

Growth rates in INR

Year on year, growth in earnings per share excluding extraordinary items increased 77.37%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		--
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.